Algae Dynamics Corp (ADYNF)

Our latest clients all have the potential to grow significantly in the near and long-term future

Re: Algae Dynamics Corp (ADYNF)

Postby QualityStocks » Wed Sep 06, 2017 4:13 pm

Algae Dynamics Corp. (ADYNF) Focuses on Cannabis Oil Vision for Medicinal Applications

- The Canadian cannabis oil extraction market is projected to reach $1.5 billion by 2020
- Algae Dynamics is focused on extracting cannabis and hemp oil, which has a range of medicinal health benefits
- Cannabis oil extracts act on the human endocannabinoid system, which includes receptors in the brain, organs, and tissues

The oils extracted from cannabis plants, especially those with high levels of cannabidiol (CBD), have been used for medicinal purposes for millennia. Algae Dynamics Corp. (OTCQB: ADYNF) has been focused on cannabis oil extraction, part of its vision to become a world leader in this field. A $1 million market in Canada in 2015, the oil extraction market is anticipated to hit $1.5 billion by 2020. Full legalization is expected across the country by July 2018, and research into the Colorado market, one of the first legal cannabis markets in the U.S., has led to estimates of 45 percent of users converting from dried marijuana to extracts and oil. The market value projections are based on similar anticipated trends for the Canadian market.

By extracting the oil from cannabis, the company aims to develop a range of health products from its derivatives. Cannabis oil, according to CBD International (http://nnw.fm/WqF8k), is beneficial for various health conditions and illnesses. The focus is cannabidiol, one of the main ingredients in marijuana. The other is tetrahydrocannabinol (THC), which is responsible for the psychotropic effects of cannabis. On the other hand, CBD does not produce a high and has been used to treat pain and epileptic seizures, as well as to slow the effects of Alzheimer’s disease. Studies have shown CBD to act on the enzymes that form amyloid plaques in the brain, which kill brain cells in people with the disease, with CBD believed to slow down this progression.

Also, CBD has antioxidant effects that can help improve heart health. It can ease pain associated with multiple sclerosis as well. Other effects of cannabis oil include boosting appetite, treating inflammatory bowel diseases such as Crohn’s disease and ulcerative colitis, and inducing a longer, more restful sleep. It’s been used to manage conditions such as anxiety, glaucoma, post-traumatic stress disorder and cancer.

Algae Dynamics Corp. is highly focused on cannabis oil extraction. Complementing it with Omega-3 oils from algae to boost the effectiveness of medicinal cannabis oils, this effort is helping the company take advantage of the traction cannabis has gained for medicinal purposes. This has been the focus of the company’s strategy for 2017, which has included university research agreements, application for a Health Canada license and supplying oil extraction equipment for the built-out oil extraction room at Bonify’s facility (a private Licensed Producer and partner).

The extracts play a significant role in human physiology. There are plant-derived cannabinoids, or phytocannabinoids, and ones produced in the human body, known as endocannabinoids. Known since the 1960s, cannabinoids have demonstrated numerous links to maintaining health. In 1992, the biological endocannabinoid system was discovered, further substantiating this connection. These compounds and their receptors are found in the brain, glands, organs, immune cells and connective tissues, leading to the development of cannabis-based oils with a number of reported health benefits.

As mentioned above, the company recently partnered with Bonify to extract cannabis oils and develop cannabis oil products (http://nnw.fm/qaf6H), with revenue to be generated from the cannabis oils the company extracts at Bonify.

For more information, visit the company’s website at www.AlgaeDynamics.com
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: Algae Dynamics Corp (ADYNF)

Postby QualityStocks » Tue Sep 12, 2017 4:13 pm

Algae Dynamics Corp. (ADYNF) Collaborating with Prominent Neuroscientist to Research Benefits of Cannabis Oil for Mental Health Disorders

- Partnership between Algae Dynamics and Dr. Steven Laviolette focuses on medical benefits of cannabis and hemp oils for various mental health disorders
- Canada is moving to legalize cannabis throughout the country in 2018, which could radically change research playing field
- Canadian cannabis oil extraction market projected to reach $1.5 billion by 2020

Algae Dynamics Corp. (OTCQB: ADYNF), a Canadian company focused on the development of proprietary research and products derived from cannabis and hemp oils, has begun a collaborative relationship with one neuroscientist who is looking deep within the brain for answers to some of the world’s most pressing mental health problems.

This research agreement with Dr. Laviolette, a neuroscientist at the University of Western Ontario, Canada, is no small thing. The level of human misery and the resulting global economic burden caused by neurological and mental health disorders is hard to fathom. The World Health Organization reports that failure to adequately address and provide effective treatment for depression and other anxiety disorders could cost the world $1 trillion each year, according to research published in The Lancet (http://nnw.fm/3kSsX).

“I started working with Algae Dynamics in the spring of this year and it’s going really well, we’re already making quite a bit of progress,” Dr. Laviolette said. “They’re very open-minded and they appreciate the science. They understand the best products come from the best quality science, so I’m very excited to be working with them.”

Algae Dynamics approached Dr. Laviolette, because he was already examining how cannabinoids can treat disorders such as addiction, schizophrenia, depression and post-traumatic stress disorder.

“We’ve been looking at how we can more effectively utilize different chemicals that are found in marijuana to serve as more effective treatments for some of these devastating illnesses,” Dr. Laviolette says. “Algae Dynamics was taking a holistic approach to this research by not only looking at the specific cannabinoids in marijuana, but they also have a background in the extraction of various nutritional dietary products such as Omega-3 fatty acids. That was very exciting for me.”

Emerging research shows that Omega-3 fatty acids can have very strong interactions with the brain’s natural or biological endocannabinoid system and can also modulate the effects of cannabinoids on the brain. If there is a dietary deficiency of Omega-3 fatty acids, the brain’s natural cannabinoid system is not going to work with optimal efficiency, Dr. Laviolette explained.

“By contrast, if you can supplement with Omega-3 fatty acids you see certain improvements in the brain’s cannabinoid system, so that immediately got us interested in how synergies between Omega-3 fatty acids and cannabinoids that are derived from marijuana might serve as potential, novel pharmaceutical and nutraceutical products for treating certain specific mental health disorders.”

The brain’s natural cannabinoid system is involved in a lot of different processes that relate to mental health, including mood regulation, one’s ability to learn and remember, and certain cognitive tasks.

“We know in certain mental health disorders like depression, addiction and schizophrenia, there’s a lot of disturbance in this cannabinoid system,” Dr. Laviolette continued. “So oftentimes people will sort of self-medicate with marijuana and perhaps expose themselves to some of the more negative aspects of it. One compound, in particular, called THC (tetrahydrocannabinol), can have negative effects, especially in younger adults, especially adolescents.”

Dr. Laviolette and his team have been comparing and contrasting THC versus other cannabinoids found in marijuana and seek to answer the question of: “What are some of the molecular pathways that they activate and how can we modulate different phytocannabinoids in their formulations and combine them with Omega-3’s to make them less likely to produce some of the negative side effects possible with marijuana exposure?”

“We’re looking at both the positive and negative effects, with the goal of really reducing or eliminating the negative effects and really sort of amplifying the positive chemicals that are found in marijuana in terms of treating some of these illnesses,” Dr. Laviolette said.

One of the biggest concerns of the medical community, and one reason a lot of doctors are not very willing to prescribe their patients cannabinoids in terms of treating mental health symptoms like PTSD, depression or even schizophrenia, relates to the potential negative side effects, he added.

“What we’re really trying to do is tease apart the positive and negative aspects of marijuana. We’ve been able to show CBD can actually be a promising treatment for a variety of mental health disorders like PTSD and schizophrenia,” Dr. Laviolette said. “It’s quite amazing because, when you think about it, it’s the same plant but these two different, competing chemicals are producing different effects in terms of mental health.”

Another major issue associated with using cannabinoids as a medical treatment is that people “aren’t really too keen on the idea of just smoking cannabinoids,” he said. “So, one of the major research directions we’re taking with Algae Dynamics is coming up with more effective non-smoked formats of medical marijuana, which includes oil-based formulations.”

Algae Dynamics’s focus on supporting research directed at the medical benefits of cannabis and hemp oils is providing a critical lifeline to scientists like Dr. Laviolette.

“The other aspect is that it’s very difficult to do this research because of all the different government regulations that you need to go through to, first; get ahold of the actual compounds, and second; get the actual license to perform these sorts of studies,” he said.

Canada is heading toward legalization of cannabis throughout the country in 2018, which could bode well for the research community, investors and companies like Algae Dynamics.

“People are excited. I think there’s a general feeling that cannabinoids are absolutely going to be an emerging biotechnology in the coming decades,” said Dr. Laviolette. “Companies like Algae Dynamics are actually taking this research seriously and are getting in on the ground floor of the development of effective cannabinoid products.”

While solid, quality research takes time, Dr. Laviolette said his team is now moving toward the clinical realm with the goal of collaborating with clinicians sometime within the next few months. Discovering the ideal ratios of THC and CBD and then combining those with a nutritional supplement such as Omega-3 fatty acids is expected to lead to the best formulations for an early stage clinical trial.

“I think there’s tremendous potential for development of pharmaceuticals and nutraceuticals based on that,” Dr. Laviolette says. “I’ve been doing this research for well over two decades now and what you consistently realize is that the existing drugs available for treating some of these symptoms have some really bad side effects. So, it’s not only the limited effectiveness of a lot of these drugs used to treat depression and anxiety, but the serious side effects that make a lot of people stop taking them. It’s essentially a barrier of sorts to long term treatment.”

Dr. Laviolette’s research is providing early, promising evidence that there are very few side effects associated with cannabidiol, or CBD, which is a non-psychoactive compound in marijuana.

“I think there’s tremendous potential to develop pharmacological treatments that are derived from natural products that are relatively pure. I think they’ll be a much more promising alternative than the more traditional medications that are out there right now,” he added.

Cannabis is a complex plant with well over 100 different phytochemicals, a fact that Dr. Laviolette describes as exciting but also one that means researchers are just barely beginning to “scratch the surface.”

For more information about Dr. Laviolette and his research with Algae Dynamics, visit the company’s website at www.AlgaeDynamics.com
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: Algae Dynamics Corp (ADYNF)

Postby QualityStocks » Fri Sep 15, 2017 4:01 pm

NetworkNewsBreaks – Algae Dynamics Corp. (ADYNF) Collaborates with Prominent Neuroscientist to Research Cannabinoid Potential in Treating Mental Health Disorders

Algae Dynamics Corp. (OTCQB: ADYNF), a Canadian company engaged in developing proprietary research as well as products derived from cannabis and hemp oils, has commenced a collaborative relationship with Dr. Laviolette, a neuroscientist at the University of Western Ontario, Canada, who is examining the treatment potential of cannabinoids in addressing disorders like addiction, schizophrenia, depression and post-traumatic stress disorder. Dr. Laviolette has been seeking ways to more effectively utilize chemicals found in marijuana to treat some of these illnesses, while Algae Dynamics has been taking a holistic approach by examining specific cannabinoids found in marijuana and combining that research with expertise in extracting various nutritional dietary products, like Omega-3 fatty acids. An article further discussing this topic reads: “Emerging research shows that Omega-3 fatty acids can have very strong interactions with the brain’s natural or biological endocannabinoid system and can also modulate the effects of cannabinoids on the brain. If there is a dietary deficiency of Omega-3 fatty acids, the brain’s natural cannabinoid system is not going to work with optimal efficiency,” Dr. Laviolette explained. “’By contrast, if you can supplement with Omega-3 fatty acids you see certain improvements in the brain’s cannabinoid system, so that immediately got us interested in how synergies between Omega-3 fatty acids and cannabinoids that are derived from marijuana might serve as potential, novel pharmaceutical and nutraceutical products for treating certain specific mental health disorders.’ The brain’s natural cannabinoid system is involved in a lot of different processes that relate to mental health, including mood regulation, one’s ability to learn and remember, and certain cognitive tasks.”
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: Algae Dynamics Corp (ADYNF)

Postby QualityStocks » Thu Sep 21, 2017 6:29 pm

Algae Dynamics Corp. (ADYNF) Collaborates with University of Western Ontario

- Research finds that higher levels of the brain chemical GABA can reverse negative effects such as schizophrenia and depression
- Professor Steven Laviolette, who spearheaded the study, hopes that GABA-increasing cannabinoid compounds developed with industrial partners from this research could lead to clinical trials “in the next few years”
- Algae Dynamics Corp. has signed a collaborative agreement with the University of Western Ontario, giving the company the patent rights to any drugs developed as a result of research

Algae Dynamics Corp. (OTCQB: ADYNF) is in a collaboration agreement with the University of Western Ontario (now rebranded as Western University), which is making international news with its recent study in Nature Scientific Reports (http://nnw.fm/aJ7Oh). The study found that the negative effects on the adolescent brain from chronic use of tetrahydrocannabinol (THC)-rich marijuana can be reversed by using compounds which increase the amounts of GABA, a chemical and neurotransmitter in the brain.

The article in Nature Scientific Reports is titled “Adolescent THC Exposure Causes Enduring Prefrontal Cortical Disruption of GABAergic Inhibition and Dysregulation of Sub-Cortical Dopamine Function.” The results have been globally reported by Global News, CBC of London, CTV News and UPI.

“What this could mean is that if you are going to be using marijuana, in a recreational or medicinal way, you can potentially combine it with compounds that boost GABA to block the negative effects of THC,” Professor Steven Laviolette of Western University’s Schulich School of Medicine and Dentistry told UPI (http://nnw.fm/yKuH2). Laviolette spearheaded the research study.

Laviolette has focused on the impact of nicotine and opiates and the neurobiology of addiction. He is studying the interface of neurobiology, psychology and emotion by using an integrative combination of behavioral neuropharmacology and vivo neuronal electrophysiology.

THC exposure reduced the GABA in the brain, the study found. GABA regulates hyperactivity in the brain and has been associated with disorders such as schizophrenia. Negative effects developed later in adulthood from use of marijuana with THC include anxiety, depression and schizophrenia. Drugs that increase the amount of GABA could then reverse the impact of THC and eliminate the schizophrenia-linked symptoms, the research found.

“We actually went in, and tried to restore the GABA system by activating GABA receptors directly in the prefrontal cortex,” Laviolette said on the Andrew Lawton radio show in Canada (http://nnw.fm/07Snd). “To our amazement, we found that this reversed those schizophrenia-like symptoms,” he added in an interview with CBC London. He explained that the reversal process can still remain effective many years after the exposure.

“What is important about this study is that not only have we developed a specific mechanism in the prefrontal mechanism for some of the mental health risks associated with adolescent marijuana use,” Laviolette told UPI. “But we have also identified a mechanism to reverse those risks.”

More research is needed to learn if boosting GABA levels would have the same results in humans as in rats, but Laviolette said that, to those people with mental health problems, there may be new hope. Laviolette told CTV News, “I think this is really a promising lead in terms of the potential of developing much safer versions of cannabinoid type drugs.”

Global News added that the next step is combining cannabinoid chemicals with compounds to boost the GABA system. The goal would be to determine better treatments for a range of other mental health disorders, such as anxiety, depression and addiction.

Laviolette, interviewed on the Lawton Show, explained that there is a need now to “dig further” into this research. The result could be more molecular pathways in the future to formulate pharmaceutical compounds with industrial partners, including the process of conducting clinical trials within the next few years. Compounds using cannabinoids may be developed in the future, he said. Cannabidiol can actually have the opposite effect of THC — negating the impact of THC.

He told Lawton that some ‘black market’ marijuana may contain up to 70% THC. THC can also increase dependency levels, he said. The reversal process may suggest larger treatment issues for schizophrenia, regardless of marijuana or THC use.

Forbes reported (http://nnw.fm/0OmnV) that another study found that chronic cannabis use can result in blunted stress reactivity. That study observed 40 cannabis users and 42 non-users to complete the stress or no-stress conditions of the Maastricht Acute Stress Test (MAST). Saliva samples and cannabis cravings and withdrawal were measured, as part of the study. Results indicated a link between higher stress ratings in non-users. In contrast, chronic cannabis users exhibited blunted stress reactivity, it said. Forbes inferred that marijuana compounds can reduce stress without the dependency of prescription medications.

While preliminary, Forbes explained, the study suggests that marijuana compounds may eventually be used to provide anxiety relief with decreased dependency, fewer side effects and reduced overdose potential.

ADYNF is engaged in the development of products and pharmaceuticals that use cannabis, hemp and algae oils. The development stage company is based in Canada and publicly traded in the U.S. The company has signed a collaboration agreement with the University of Western Ontario, enabling the firm to retain the rights to patents developed in conjunction with the school. Western University is focused on the areas of depression, post-traumatic stress disorder, anxiety and schizophrenia.

According to an ADYNF corporate presentation (http://nnw.fm/HNa1I), the company is building its intellectual property portfolio in the pharmaceutical field. Its goal is to develop value-added products, supported by strong science and clinical trials, combining the benefits of algae and cannabis oils to enhance efficacy in a unique and patented way.

For more information, visit the company’s website at www.AlgaeDynamics.com
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: Algae Dynamics Corp (ADYNF)

Postby QualityStocks » Fri Sep 29, 2017 4:29 pm

NetworkNewsBreaks – Algae Dynamics Corp. (ADYNF) Collaborative Study Yields Possible Breakthrough in Reversing Mental Illness Symptoms Resulting from Adolescent Cannabis Use

Algae Dynamics Corp. (OTCQB: ADYNF), a company engaged in developing unique health products and pharmaceuticals that utilize hemp, cannabis and algae oils, is making international news through its current collaboration with the University of Western Ontario (now rebranded as Western University). A recent study conducted collaboratively between the two entities and globally reported (http://nnw.fm/aJ7Oh) has found that the negative effects of tetrahydrocannabinol (THC)-rich marijuana on the adolescent brain can be reversed through the use of compounds that increase the amounts of GABA, which is a chemical and neurotransmitter in the brain. An article further discussing this reads: “THC exposure reduced the GABA in the brain, the study found. GABA regulates hyperactivity in the brain and has been associated with disorders such as schizophrenia. Negative effects developed later in adulthood from use of marijuana with THC include anxiety, depression and schizophrenia. Drugs that increase the amount of GABA could then reverse the impact of THC and eliminate the schizophrenia-linked symptoms, the research found. ‘We actually went in, and tried to restore the GABA system by activating GABA receptors directly in the prefrontal cortex,’ Western University Professor Steven Laviolette, who spearheaded the research study, said on the Andrew Lawton radio show in Canada (http://nnw.fm/07Snd). ‘To our amazement, we found that this reversed those schizophrenia-like symptoms,’ he added in an interview with CBC London. He explained that the reversal process can still remain effective many years after the exposure.”
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: Algae Dynamics Corp (ADYNF)

Postby QualityStocks » Mon Oct 02, 2017 3:55 pm

Algae Dynamics Corp. (ADYNF) Research Efforts Focus on Healthier Benefits of Cannabis Oils

- Health conscious consumers favor cannabis oil extracts and edibles over smoking
- Recent survey shows 46% of Canadians would try cannabis-infused products
- Canadian cannabis oil extraction market expected to reach $1.7 billion by 2020

Algae Dynamics Corp (OTC: ADYNF) is uniquely positioned to benefit from the upcoming legalization of recreational marijuana in Canada by mid-2018. The company’s focus on developing proprietary research and products involving botanical oils derived from cannabis combines two important consumer demands – the well-known health benefits of cannabinoids and a smoke-free alternative to cannabis consumption.

Nearly half of Canadians (46%) polled in August 2017 by Dalhousie University researchers in Nova Scotia (http://nnw.fm/93M0q) said they are interested in trying edible marijuana once recreational marijuana is legalized within the country. To clarify, medical marijuana has been legal in Canada since 2001, with some provisions, and the new law will only allow consumers to purchase dried marijuana and cannabis oil.

The preliminary study, entitled “Cannabis-infused food and Canadian consumers’ willingness to consider marijuana as a food ingredient,” was led by Dr. Sylvain Charlebois, a professor in food distribution and policy on the Faculty of Management at Dalhousie University. Among the findings, the survey shows that the majority of the 1,087 Canadians (68%) surveyed are supportive of legalizing marijuana, and cannabis-infused baked goods, cannabis oils and spices are high on the list of things to try (http://nnw.fm/9aS0X).

Algae Dynamics and its marketing team are actively preparing to respond to an increased market demand once legalization takes place. The company cites a 2016 Mackie Research Capital Corp. estimate involving trends in Colorado, one of the first U.S. states to legalize marijuana, which found that 45% of dried marijuana users would eventually convert to marijuana extracts and/or oils. Algae Dynamics’ strategy includes extracting oils from cannabis and hemp to formulate unique health and nutraceutical products, along with the distinction of becoming a leading medical cannabis producer through its association with two of Canada’s leading research universities – the University of Waterloo and the University of Western Ontario. This collaborative research is focused on the use of extracts from cannabis oil in the context of various forms of cancer, in addition to development of new pharmacotherapies for mental health.

Algae Dynamics has also signed a letter of intent with a licensed cannabis producer that has the capability to grow multiple strains of the highly regulated plant in a state-of-the-art facility. This agreement with 6779264 Manitoba Ltd., dba Bonify, gives Algae Dynamics an improved pathway to early revenues as well as a high-quality source of cannabis oil to support the research already underway at the universities.

Cannabis oils are increasingly being seen by consumers as a much healthier avenue when it comes to cannabis consumption. The Canadian government has stated its intent to delay legalization of edibles past the planned July 1, 2018, deadline (http://nnw.fm/HX66n). Instead, the government indicates that it will focus on making products like fresh or dried cannabis, cannabis oils, seeds and plants available for legal purchase.

The underserved market for licensed cannabis producers in Canada, which currently has only 59 licensed producers to serve the country’s population of 35 million, offers great potential for Algae Dynamics. As part of its strategy to be the number one Canadian cannabis research-driven product formulator, Algae Dynamics relies on a formidable leadership team of scientific and strategic advisors that complement the company’s ongoing research and development relationships and initiatives.

For more information, visit the company’s website at www.AlgaeDynamics.com
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: Algae Dynamics Corp (ADYNF)

Postby QualityStocks » Fri Oct 06, 2017 4:02 pm

Algae Dynamics Corp. (ADYNF) Takes the Safe Road in Cannabis Delivery

- Focused on developing remedies from cannabis oil
- Research programs in conjunction with Universities of Waterloo & Western Ontario
- Strategy to capture market share of non-smoke MMJ nutraceuticals

To acquire the benefits of cannabis, there are many pathways, with some being distinctly safer than others. There are tinctures and topicals; there is dabbing; and there is vaping. There are drinks and digestibles and, of course, there is smoking. Over the last few decades, what some wits refer to as ‘puffing the magic dragon’ has emerged as the top delivery method for users of cannabis, but smoking harms nearly every organ of the body and causes many diseases, according to the Centers for Disease Control (CDC) (http://nnw.fm/CA7Pe). Given such adverse aftereffects, interest in safer delivery options, like those made possible by technology from Algae Dynamics Corp. (OTC: ADYNF), has grown. Algae Dynamics is an innovative biotech currently engaged in the development of nutraceuticals and pharmaceuticals utilizing hemp, cannabis and algae oils. The company plans to be a global leader in the formulation and development of health products from cannabis derivatives, algae oils and other botanical oils.

The days when inhaling and exhaling tobacco fumes was regarded as chic or sophisticated are long gone. Now that the danger from cigarettes has been laid bare, the glamour long associated with them has evaporated much as their smoke does. Smoking is responsible for about 480,000 deaths each year in the United States; that is nearly one in five deaths, a figure that exceeds the combined fatalities due to HIV, illegal drug use, alcohol, motor vehicle accidents and gun-related incidents. Notably, ‘more than 10 times as many U.S. citizens have died prematurely from cigarette smoking than have died in all the wars fought by the United States’, according to the U.S. Surgeon General (http://nnw.fm/4DSlH). These compelling statistics, together with government and private initiatives, have raised awareness of the threats posed by smoking, which extend not only to the use of tobacco but also to the newly emerging therapeutic treatments based on cannabis.

In response to the imperative for safer delivery of cannabinoids, Algae Dynamics has been working with two of Canada’s leading research universities – the University of Western Ontario and the University of Waterloo. This collaborative research is focused on the use of extracts from cannabis oil to treat some mental health issues and various forms of cancer. The program at the University of Western Ontario is studying the effects of cannabis oil on depression, post-traumatic stress disorder (PTSD), anxiety and schizophrenia, while research at the University of Waterloo is examining ways of treating colorectal, pancreas, breast and prostate cancers.

To support these research efforts, Algae Dynamics announced in August 2017 that it would be collaborating with Bonify, a Licensed Producer (LP), under the Access to Cannabis for Medical Purposes Regulations (ACMPR) in Canada, to engage in the extraction of cannabis oil, according to MarketWatch (http://nnw.fm/Cb1wu). The joint initiative entails the purchase and installation of cannabis oil extraction equipment by ADYNF at Bonify’s facility in Winnipeg, Canada. This deal will secure cannabis material for extraction and will generate revenue. As well, the cannabis oil thus produced will be supplied to the University of Waterloo and University of Western Ontario to support the Sponsored Research Agreements that ADYNF has in place with the two universities.

The market for cannabis oil is still in its embryonic stage, but it is likely to grow quickly, spurred by recent trends. A 2016 Mackie Research Capital report, extrapolating data from Colorado, one of the first U.S. states to legalize marijuana, estimates that 45 percent of dried marijuana users would eventually convert to marijuana extracts and/or oils. New Cannabis Ventures even billed cannabis extracts as ‘The Next Canadian Oil Boom’ (http://nnw.fm/a4dOI) after a court ruling allowing LPs to produce cannabis extracts. The Canadian cannabis oil extraction market is projected to grow to C$1.7 billion by 2020. With legalization for recreational use set for July 2018, safer delivery routes for cannabis therapeutics like those engineered by Algae Dynamics are sorely needed to help customers and patients avoid the hazards of smoking.

For more information, visit the company’s website at www.AlgaeDynamics.com
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: Algae Dynamics Corp (ADYNF)

Postby QualityStocks » Fri Oct 06, 2017 4:21 pm

NetworkNewsBreaks – Algae Dynamics Corp. (ADYNF) Prepares for Increased Cannabis Demand in Canada

Algae Dynamics Corp. (OTC: ADYNF), a company engaged in developing unique health products and pharmaceuticals utilizing cannabis and algae oils, is well-positioned to benefit from the impending legalization of recreational marijuana in Canada, which the Canadian government is endeavoring to accomplish by mid-2018. The company’s focus on the development of proprietary research and products utilizing cannabis-derived botanical oils addresses two areas of key interest to consumers: the noted health benefits of cannabinoids and smoke-free alternatives for marijuana consumption. An article discussing this reads: “Algae Dynamics and its marketing team are actively preparing to respond to an increased market demand once legalization takes place. The company cites a 2016 Mackie Research Capital Corp. estimate involving trends in Colorado, one of the first U.S. states to legalize marijuana, which found that 45% of dried marijuana users would eventually convert to marijuana extracts and/or oils. Algae Dynamics’ strategy includes extracting oils from cannabis and hemp to formulate unique health and nutraceutical products, along with the distinction of becoming a leading medical cannabis producer through its association with two of Canada’s leading research universities – the University of Waterloo and the University of Western Ontario. This collaborative research is focused on the use of extracts from cannabis oil in the context of various forms of cancer, in addition to development of new pharmacotherapies for mental health.”
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: Algae Dynamics Corp (ADYNF)

Postby QualityStocks » Fri Oct 13, 2017 5:15 pm

Algae Dynamics Corp. (ADYNF) Sees Opportunity for Hemp, Algae, and CBD Oils in Expanding Canadian Marijuana Market

- Canadian marijuana market seen as C$2.8 billion by CY2020, a 30% YOY gain, research study projects.
- Extracts/oil from cannabis (CBD) sales by CY2020 will surpass dried marijuana by wide margin.
- Marijuana seen as being fully legalized in Canada by July 2018.

Algae Dynamics Corp. (OTCQB: ADYNF) sees opportunity and greater market share in a soon to be legalized marijuana industry in Canada, where registered clients are estimated to grow to 715,000 by CY2020, cumulatively purchasing 124,443 kilograms (kg) of dried medical marijuana annually, a 31% YOY increase, a study by Mackie Research found (http://nnw.fm/9yGcp). If the Colorado model remains true, some 45% of those buyers will switch by 2018 from dried medical marijuana to marijuana extracts/oil, creating a market of 239,998 liters in extracts/oil alone.

That’s good news for ADYNF, a producer of health products and nutraceuticals that utilizes extraction of cannabis, hemp, and algae oils in its products. It is a development-stage company with a portfolio of intellectual property and a signed agreement with a Licensed Producer. ADYNF is an Ontario, Canada-based company, but it is publicly traded in the U.S. Because it is located in Canada, it is free of all exposure to any U.S. federal regulations or restrictions of cannabis.

Legalization of marijuana in Canada is widely expected by July 2018 (http://nnw.fm/7DpDI). If that happens, Mackie research projects that the Canadian market for both dried marijuana and extracts/oil would be an estimated C2.8 billion in CY2018, a 30% YOY increase. By that year, sales of extracts/oil would surpass revenues from dried marijuana by C1.687 billion to C1.113 billion.

ADYNF collaborates with the University of Waterloo and University of Western Ontario in research, formulations and product development, with the company maintaining patent rights on the research findings. The goal is to develop premium, patented health products.

Most recently, in collaboration with the University of Western Ontario, it was found that higher levels of the brain chemical GABA can help reverse in adults the negative effects of THC-infused marijuana ingested when in adolescence. The findings, published in Nature Scientific Reports (http://nnw.fm/pN6Du), earned ADYNF international press recognition.

For more information, refer to www.algaedynamics.com.
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: Algae Dynamics Corp (ADYNF)

Postby QualityStocks » Thu Oct 19, 2017 5:18 pm

NetworkNewsBreaks – Canada’s Cannabis Market Presents Big Potential for Algae Dynamics Corp. (ADYNF)

In Canada, where recreational marijuana is expected to be legalized in 2018 and where registered clients are projected to increase to 715,000 by 2020 and cumulatively purchase 124,443 kg of dried medical marijuana annually, Algae Dynamics Corp. (OTCQB: ADYNF) foresees huge opportunity and greater market share. If the model seen in Colorado’s cannabis market holds true, by 2018 approximately 45 percent of Canada’s cannabis consumers will have switched from dried medical marijuana to cannabis extracts/oil. This is great news for ADYNF, which produces health products and nutraceuticals utilizing cannabis, hemp and algae oils. An article discussing this reads: “(ADYNF) is a development-stage company with a portfolio of intellectual property and a signed agreement with a Licensed Producer. ADYNF is an Ontario, Canada-based company, but it is publicly traded in the U.S. Because it is located in Canada, it is free of all exposure to any U.S. federal regulations or restrictions of cannabis. Legalization of marijuana in Canada is widely expected by July 2018 (http://nnw.fm/7DpDI). If that happens, Mackie research projects that the Canadian market for both dried marijuana and extracts/oil would be an estimated C2.8 billion in CY2018, a 30% YOY increase. By that year, sales of extracts/oil would surpass revenues from dried marijuana by C1.687 billion to C1.113 billion.”
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: Algae Dynamics Corp (ADYNF)

Postby QualityStocks » Wed Nov 01, 2017 6:20 pm

NetworkNewsBreaks – Algae Dynamics Corp. (ADYNF) Continues Collaborative Research on Safer Cannabinoid Delivery

Innovative biotech company Algae Dynamics Corp. (OTCQB: ADYNF) is engaged in the development of nutraceuticals and pharmaceuticals utilizing hemp, cannabis and algae oils. The company also aims to create a safe delivery method of cannabinoids and is currently working toward this goal with two universities in Canada. An article discussing this reads: “In response to the imperative for safer delivery of cannabinoids, Algae Dynamics has been working with two of Canada’s leading research universities – the University of Western Ontario and the University of Waterloo. This collaborative research is focused on the use of extracts from cannabis oil to treat some mental health issues and various forms of cancer. The program at the University of Western Ontario is studying the effects of cannabis oil on depression, post-traumatic stress disorder (PTSD), anxiety and schizophrenia, while research at the University of Waterloo is examining ways of treating colorectal, pancreas, breast and prostate cancers.”
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: Algae Dynamics Corp (ADYNF)

Postby QualityStocks » Wed Nov 15, 2017 6:29 pm

NetworkNewsBreaks – Algae Dynamics Corp. (ADYNF) Receives $250,000 Investment to Enhance Existing University Research Programs

Algae Dynamics (OTC: ADYNF), developer of unique health products infused with cannabis and algae oils, has received an investment of $250,000 from Teewinot Life Sciences Corporation, developer of biosynthetic cannabinoids. Algae Dynamics says it will use the funds for its research programs with The University of Waterloo and University of Western Ontario, as well as general administrative and compliance purposes. “These funds will allow us to continue our important university research programs and provide resources to move forward at an accelerated pace. We believe this new relationship with Teewinot will provide strategic value that will provide long term benefits for all of our key stakeholders,” Algae Dynamics chairman and President Paul Ramsay stated in the news release.
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Re: Algae Dynamics Corp (ADYNF)

Postby QualityStocks » Thu Nov 16, 2017 7:59 pm

NetworkNewsBreaks – Algae Dynamics Corp. (ADYNF) Receives Grant from Mitacs for Cannabis Research Collaboration

Innovative biotech company Algae Dynamics Corp. (OTCQB: ADYNF) this morning said the company, together with the University of Western Ontario, received project funding in the form of a C$400,000 grant from Mitacs, a Canadian not-for-profit organization. The company previously announced a research agreement with the University of Western Ontario to examine the role of specific phytochemicals in marijuana for the development of novel mental health therapies. The grant will support the collaborative project to identify and produce specific cannabinoid oil formulations with ratios that selectively target symptoms associated with these specific diseases. “This grant provides tremendous support to our sponsored research program with the University of Western Ontario and will accelerate development of nutraceutical product formulations, which is our core mission,” Algae Dynamics chairman and president Paul Ramsay stated in the news release.
The QualityStocks Daily Newsletter http://Newsletter.QualityStocks.net

The QualityStocks Daily Blogs http://Blog.QualityStocks.net

Please read FULL Compensation Disclosures and other disclaimers at http://www.qualitystocks.net/disclaimer.php
QualityStocks
Site Admin
 
Posts: 944
Joined: Mon May 21, 2007 7:58 pm
Location: Scottsdale, AZ

Previous

Return to QualityStocks Featured Companies

Who is online

Users browsing this forum: No registered users and 1 guest

cron